Covalent binding of ethidium azide analogs to Salmonella DNA in vivo: competition by ethidium bromide.

L. Yielding,D. Graves,B. R. Brown,K. L. Yielding

DOI: https://doi.org/10.1016/0006-291X(79)91813-8

1979-03-30

Abstract:

What problem does this paper attempt to address?

Induction of Autonomous Memory Alveolar Macrophages Requires T Cell Help and is Critical to Trained Immunity

Y. Yao,M. Jeyanathan,S. Haddadi,N. Barra,M. Vaseghi-Shanjani,D. Damjanovic,R. Lai,S. Afkhami,Y. Chen,A. Dvorkin-Gheva,C. Robbins,J. Schertzer,Z. Xing

DOI: https://doi.org/10.1016/j.cell.2018.09.042

IF: 64.5

2018-01-01

Cell

Abstract:Innate immune memory is an emerging area of research. However, innate immune memory at major mucosal sites remains poorly understood. Here, we show that respiratory viral infection induces long-lasting memory alveolar macrophages (AMs). Memory AMs are programed to express high MHC II, a defense-ready gene signature, and increased glycolytic metabolism, and produce, upon re-stimulation, neutrophil chemokines. Using a multitude of approaches, we reveal that the priming, but not maintenance, of memory AMs requires the help from effector CD8 T cells. T cells jump-start this process via IFN-γ production. We further find that formation and maintenance of memory AMs are independent of monocytes or bone marrow progenitors. Finally, we demonstrate that memory AMs are poised for robust trained immunity against bacterial infection in the lung via rapid induction of chemokines and neutrophilia. Our study thus establishes a new paradigm of immunological memory formation whereby adaptive T-lymphocytes render innate memory of mucosal-associated macrophages.
Innate Immune Memory Of Tissue-Resident Macrophages And Trained Innate Immunity: Re-Vamping Vaccine Concept And Strategies

Zhou Xing,Sam Afkhami,Jegarubee Bavananthasivam,Dominik K. Fritz,Michael R. D'Agostino,Maryam Vaseghi-Shanjani,Yushi Yao,Mangalakumari Jeyanathan

DOI: https://doi.org/10.1002/JLB.4MR0220-446R

2020-01-01

Journal of Leukocyte Biology

Abstract:In the past few years, our understanding of immunological memory has evolved remarkably due to a growing body of new knowledge in innate immune memory and immunity. Immunological memory now encompasses both innate and adaptive immune memory. The hypo-reactive and hyper-reactive types of innate immune memory lead to a suppressed and enhanced innate immune protective outcome, respectively. The latter is also named trained innate immunity (TII). The emerging information on innate immune memory has not only shed new light on the mechanisms of host defense but is also revolutionizing our long-held view of vaccination and vaccine strategies. Our current review will examine recent progress and knowledge gaps in innate immune memory with a focus on tissue-resident M phi s, particularly lung M phi s, and their relationship to local antimicrobial innate immunity. We will also discuss the impact of innate immune memory and TII on our understanding of vaccine concept and strategies and the significance of respiratory mucosal route of vaccination against respiratory pathogens.
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M Dan,Jose Mateus,Yu Kato,Kathryn M Hastie,Esther Dawen Yu,Caterina E Faliti,Alba Grifoni,Sydney I Ramirez,Sonya Haupt,April Frazier,Catherine Nakao,Vamseedhar Rayaprolu,Stephen A Rawlings,Bjoern Peters,Florian Krammer,Viviana Simon,Erica Ollmann Saphire,Davey M Smith,Daniela Weiskopf,Alessandro Sette,Shane Crotty,Jennifer M. Dan,Kathryn M. Hastie,Caterina E. Faliti,Sydney I. Ramirez,Stephen A. Rawlings,Davey M. Smith

DOI: https://doi.org/10.1126/science.abf4063

IF: 56.9

2021-02-05

Science

Abstract:Variable memory Immune memory against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) helps to determine protection against reinfection, disease risk, and vaccine efficacy. Using 188 human cases across the range of severity of COVID-19, Dan et al. analyzed cross-sectional data describing the dynamics of SARS-CoV-2 memory B cells, CD8 + T cells, and CD4 + T cells for more than 6 months after infection. The authors found a high degree of heterogeneity in the magnitude of adaptive immune responses that persisted into the immune memory phase to the virus. However, immune memory in three immunological compartments remained measurable in greater than 90% of subjects for more than 5 months after infection. Despite the heterogeneity of immune responses, these results show that durable immunity against secondary COVID-19 disease is a possibility for most individuals. Science , this issue p. eabf4063

multidisciplinary sciences
The effect of neurosphere culture conditions on the cellular metabolism of glioma cells.

U. Kahlert,K. Koch,A. Suwala,R. Hartmann,M. Cheng,D. Maciaczyk,D. Willbold,C. Eberhart,K. Glunde,J. Maciaczyk

DOI: https://doi.org/10.5114/fn.2015.54422

2015-09-29

Folia Neuropathologica

Abstract:Malignant gliomas, with an average survival time of 16-19 months after initial diagnosis, account for one of the most lethal tumours overall. Current standards in patient care provide only unsatisfying strategies in diagnostic and treatment for high-grade gliomas. Here we describe metabolic phenomena in the choline and glycine network associated with stem cell culture conditions in the classical glioma cell line U87. Using high-resolution proton magnetic resonance spectroscopy of cell culture metabolic extracts we compare the metabolic composition of U87 chronically propagated as adherent culture in medium supplemented with serum to serum-free neurosphere growth. We found that the switch to neurosphere growth, besides the increase of cells expressing the putative glioma stem cell marker CD133, modulated a number of intracellular metabolites including choline, creatine, glycine, and myo-inositol that have been previously reported as potential diagnostic markers in various tumours. These findings highlight the critical influence of culture conditions on glioma cell metabolism, and therefore particular caution should be drawn to the use of in vitro system research in order to investigate cancer metabolism.
Behavior-based involvement recognized in OSHA voluntary protection programs. Meaningful employee involvement satisfies OSHA and helps the corporate bottom line.

T. Krause

Abstract:
Tissue resident memory T cells in the respiratory tract

Ming Z. M. Zheng,Linda M. Wakim

DOI: https://doi.org/10.1038/s41385-021-00461-z

IF: 9.02

2021-10-20

Mucosal Immunology

Abstract:Owing to their capacity to rapidly spread across the population, airborne pathogens represent a significant risk to global health. Indeed, several of the past major global pandemics have been instigated by respiratory pathogens. A greater understanding of the immune cells tasked with protecting the airways from infection will allow for the development of strategies that curb the spread and impact of these airborne diseases. A specific subset of memory T-cell resident in both the upper and lower respiratory tract, termed tissue-resident memory (Trm), have been shown to play an instrumental role in local immune responses against a wide breadth of both viral and bacterial infections. In this review, we discuss factors that influence respiratory tract Trm development, longevity, and immune surveillance and explore vaccination regimes that harness these cells, such approaches represent exciting new strategies that may be utilized to tackle the next global pandemic.

immunology
Human Nasal and Lung Tissues Infected Ex Vivo with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract

Or Alfi,Arkadi Yakirevitch,Ori Wald,Ori Wandel,Uzi Izhar,Esther Oiknine-Djian,Yuval Nevo,Sharona Elgavish,Elad Dagan,Ory Madgar,Gilad Feinmesser,Eli Pikarsky,Michal Bronstein,Olesya Vorontsov,Wayne Jonas,John Ives,Joan Walter,Zichria Zakay-Rones,Menachem Oberbaum,Amos Panet,Dana G Wolf

DOI: https://doi.org/10.1128/JVI.00130-21

2021-06-24

Abstract:The nasal mucosa constitutes the primary entry site for respiratory viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While the imbalanced innate immune response of end-stage coronavirus disease 2019 (COVID-19) has been extensively studied, the earliest stages of SARS-CoV-2 infection at the mucosal entry site have remained unexplored. Here, we employed SARS-CoV-2 and influenza virus infection in native multi-cell-type human nasal turbinate and lung tissues ex vivo, coupled with genome-wide transcriptional analysis, to investigate viral susceptibility and early patterns of local mucosal innate immune response in the authentic milieu of the human respiratory tract. SARS-CoV-2 productively infected the nasal turbinate tissues, predominantly targeting respiratory epithelial cells, with a rapid increase in tissue-associated viral subgenomic mRNA and secretion of infectious viral progeny. Importantly, SARS-CoV-2 infection triggered robust antiviral and inflammatory innate immune responses in the nasal mucosa. The upregulation of interferon-stimulated genes, cytokines, and chemokines, related to interferon signaling and immune-cell activation pathways, was broader than that triggered by influenza virus infection. Conversely, lung tissues exhibited a restricted innate immune response to SARS-CoV-2, with a conspicuous lack of type I and III interferon upregulation, contrasting with their vigorous innate immune response to influenza virus. Our findings reveal differential tissue-specific innate immune responses in the upper and lower respiratory tracts that are specific to SARS-CoV-2. The studies shed light on the role of the nasal mucosa in active viral transmission and immune defense, implying a window of opportunity for early interventions, whereas the restricted innate immune response in early-SARS-CoV-2-infected lung tissues could underlie the unique uncontrolled late-phase lung damage of advanced COVID-19. IMPORTANCE In order to reduce the late-phase morbidity and mortality of COVID-19, there is a need to better understand and target the earliest stages of SARS-CoV-2 infection in the human respiratory tract. Here, we have studied the initial steps of SARS-CoV-2 infection and the consequent innate immune responses within the natural multicellular complexity of human nasal mucosal and lung tissues. Comparing the global innate response patterns of nasal and lung tissues infected in parallel with SARS-CoV-2 and influenza virus, we found distinct virus-host interactions in the upper and lower respiratory tract, which could determine the outcome and unique pathogenesis of SARS-CoV-2 infection. Studies in the nasal mucosal infection model can be employed to assess the impact of viral evolutionary changes and evaluate new therapeutic and preventive measures against SARS-CoV-2 and other human respiratory pathogens.
Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children

Qin Xu,Pedro Milanez-Almeida,Andrew J. Martins,Andrea J. Radtke,Kenneth B. Hoehn,Cihan Oguz,Jinguo Chen,Can Liu,Juanjie Tang,Gabrielle Grubbs,Sydney Stein,Sabrina Ramelli,Juraj Kabat,Hengameh Behzadpour,Maria Karkanitsa,Jacquelyn Spathies,Heather Kalish,Lela Kardava,Martha Kirby,Foo Cheung,Silvia Preite,Patrick C. Duncker,Moses M. Kitakule,Nahir Romero,Diego Preciado,Lyuba Gitman,Galina Koroleva,Grace Smith,Arthur Shaffer,Ian T. McBain,Peter J. McGuire,Stefania Pittaluga,Ronald N. Germain,Richard Apps,Daniella M. Schwartz,Kaitlyn Sadtler,Susan Moir,Daniel S. Chertow,Steven H. Kleinstein,Surender Khurana,John S. Tsang,Pamela Mudd,Pamela L. Schwartzberg,Kalpana Manthiram

DOI: https://doi.org/10.1038/s41590-022-01367-z

IF: 30.5

2022-12-20

Nature Immunology

Abstract:Most studies of adaptive immunity to SARS-CoV-2 infection focus on peripheral blood, which may not fully reflect immune responses at the site of infection. Using samples from 110 children undergoing tonsillectomy and adenoidectomy during the COVID-19 pandemic, we identified 24 samples with evidence of previous SARS-CoV-2 infection, including neutralizing antibodies in serum and SARS-CoV-2-specific germinal center and memory B cells in the tonsils and adenoids. Single-cell B cell receptor (BCR) sequencing indicated virus-specific BCRs were class-switched and somatically hypermutated, with overlapping clones in the two tissues. Expanded T cell clonotypes were found in tonsils, adenoids and blood post-COVID-19, some with CDR3 sequences identical to previously reported SARS-CoV-2-reactive T cell receptors (TCRs). Pharyngeal tissues from COVID-19-convalescent children showed persistent expansion of germinal center and antiviral lymphocyte populations associated with interferon (IFN)-γ-type responses, particularly in the adenoids, and viral RNA in both tissues. Our results provide evidence for persistent tissue-specific immunity to SARS-CoV-2 in the upper respiratory tract of children after infection.

immunology
Innate memory against viruses

Paula Jauregui

DOI: https://doi.org/10.1038/s41590-024-02009-2

IF: 30.5

2024-10-29

Nature Immunology

Abstract:Innate immune memory provides antigen-independent cross-protection against heterologous pathogens. In Immunity , Lercher et al. determine the effects of innate immune memory in airway-resident immune cells on disease outcome of a second heterologous viral infection. The authors use a mouse-adapted SARS-CoV-2 strain for a murine infection model of SARS-CoV-2 recovery. They investigate the epigenetic and transcriptomics changes in airway-resident cells by single-nuclei combined assay of transposase-accessible chromatin with sequencing (snATAC-seq)/RNA sequencing (snRNA-seq) and find that alveolar macrophages present epigenetic imprinting after SARS-CoV-2 infection. Human monocytes from individuals after SARS-CoV-2 infection also retained epigenetic programs. Using an ex vivo culture of mouse primary airway-resident macrophages stimulated with different pattern recognition receptor agonists the authors show that the epigenetic imprinting associated with previous SARS-CoV-2 infection results in antiviral innate immune memory. The authors challenged mice that had recovered from SARS-CoV-2 with influenza A virus and observed milder pathology. Similar results were obtained after transferring airway-resident macrophages isolated from recovered mice into T cell-depleted naive recipient mice. Past SARS-CoV-2 infection ameliorates the pathology associated with secondary influenza A virus infection. Original reference: Immunity https://doi.org/10.1016/j.immuni.2024.08.018 (2024)

immunology
Temporal High-Resolution Atlas of Human Blood Leukocyte Composition in Response to Respiratory Virus Inoculation

Yu Zhang,Tianyi Liu,Chuwen Liu,Xuejun Sun,Pei Liu,James S. Hagood,Raymond J. Pickles,Fei Zou,Xiaojing Zheng

DOI: https://doi.org/10.1101/2024.10.01.616122

2024-10-03

Abstract:Viral respiratory infections are a significant global health burden. Human immune responses to infections caused by respiratory viruses are complex and dependent on the length of time the host has been infected. Human viral challenge studies provide a useful opportunity to understand the timing of human immune responses as samples can be obtained pre-inoculation and post-inoculation by defined virus inocula. Transcriptomic data is available from a large amount of publicly available viral challenge studies and genome-wide transcriptomic data is primarily derived from bulk samples containing mixed cell subpopulations. Traditional bulk transcriptomic analysis methods often utilize deconvolution techniques to study changes in cell proportions of major immune cell types. In this study, we digitally sorted the cellular diversity of 31 blood immune cell types over time in human challenge studies after inoculation by H3N2 influenza virus H1N1 influenza virus, and RSV using xCell, a digital cell separation method, on human bulk transcriptional repository data. We identified common inoculation-induced changes in cell subpopulations across studies of the three viruses with time kinetics. We observed a consistent elevation of myeloid cells and their subtypes post-inoculation across various viral inoculations. Lymphocytes and their subpopulations were reduced in symptomatic and infected (Sx/Inf) participants compared to asymptomatic and uninfected (Asx/Uninf) participants. H3N2 evoked the earliest transcriptional immune responses, followed by H1N1, RSV infection elicited a delayed transcriptional response compared to both influenza viruses likely due to slower replication kinetics. Our analysis also revealed unique immune cell composition changes caused by specific viruses. We found that pre-existing baseline memory T cells were associated with resistance to influenza viral infection and that the key cell type is effector memory (Tem) CD8 T cells. These findings identify specific target cell subpopulations which respond to respiratory virus inoculation over time, shedding light on mechanisms for eliciting a robust baseline level of immune memory against multiple viral strains. These studies highlight potential immune cell responses that can be utilized to enhance vaccine design.

Biology
Lung-resident memory B cells established after pulmonary influenza infection display distinct transcriptional and phenotypic profiles

Hyon-Xhi Tan,Jennifer A. Juno,Robyn Esterbauer,Hannah G. Kelly,Kathleen M. Wragg,Penny Konstandopoulos,Sheilajen Alcantara,Carolina Alvarado,Robert Jones,Graham Starkey,Boa Zhong Wang,Osamu Yoshino,Thomas Tiang,M. Lindsay Grayson,Helen Opdam,Rohit D’Costa,Angela Vago,Laura K. Mackay,Claire L. Gordon,David Masopust,Joanna R. Groom,Stephen J. Kent,Adam K. Wheatley,

DOI: https://doi.org/10.1126/sciimmunol.abf5314

IF: 30.63

2022-01-28

Science Immunology

Abstract:Recent studies have established that memory B cells, largely thought to be circulatory in the blood, can take up long-term residency in inflamed tissues, analogous to widely described tissue-resident T cells. The dynamics of recruitment and retention of memory B cells to tissues and their immunological purpose remains unclear. Here, we characterized tissue-resident memory B cells (B RM ) that are stably maintained in the lungs of mice after pulmonary influenza infection. Influenza - specific B RM were localized within inducible bronchus-associated lymphoid tissues (iBALTs) and displayed transcriptional signatures distinct from classical memory B cells in the blood or spleen while showing partial overlap with memory B cells in lung-draining lymph nodes. We identified lung-resident markers, including elevated expression of CXCR3, CCR6, and CD69, on hemagglutinin (HA)– and nucleoprotein (NP)–specific lung B RM . We found that CCR6 facilitates increased recruitment and/or retention of B RM in lungs and differentiation into antibody-secreting cells upon recall. Although expression of CXCR3 and CCR6 was comparable in total and influenza-specific memory B cells isolated across tissues of human donors, CD69 expression was higher in memory B cells from lung and draining lymph nodes of human organ donors relative to splenic and PBMC-derived populations, indicating that mechanisms underpinning B RM localization may be evolutionarily conserved. Last, we demonstrate that human memory B cells in lungs are transcriptionally distinct to populations in lung-draining lymph nodes or PBMCs. These data suggest that B RM may constitute a discrete component of B cell immunity, positioned at the lung mucosa for rapid humoral response against respiratory viral infections.

immunology
Immune cell residency in the nasal mucosa may partially explain respiratory disease severity across the age range

Konner Winkley,Dithi Banerjee,Todd Bradley,Boryana Koseva,Warren A. Cheung,Rangaraj Selvarangan,Tomi Pastinen,Elin Grundberg

DOI: https://doi.org/10.1038/s41598-021-95532-3

IF: 4.6

2021-08-05

Scientific Reports

Abstract:Abstract Previous studies focusing on the age disparity in COVID-19 severity have suggested that younger individuals mount a more robust innate immune response in the nasal mucosa after infection with SARS-CoV-2. However, it is unclear if this reflects increased immune activation or increased immune residence in the nasal mucosa. We hypothesized that immune residency in the nasal mucosa of healthy individuals may differ across the age range. We applied single-cell RNA-sequencing and measured the cellular composition and transcriptional profile of the nasal mucosa in 35 SARS-CoV-2 negative children and adults, ranging in age from 4 months to 65 years. We analyzed in total of ~ 30,000 immune and epithelial cells and found that age and immune cell proportion in the nasal mucosa are inversely correlated, with little evidence for structural changes in the transcriptional state of a given cell type across the age range. Orthogonal validation by epigenome sequencing indicate that it is especially cells of the innate immune system that underlie the age-association. Additionally, we characterize the predominate immune cell type in the nasal mucosa: a resident T cell like population with potent antiviral properties. These results demonstrate fundamental changes in the immune cell makeup of the uninfected nasal mucosa over the lifespan. The resource we generate here is an asset for future studies focusing on respiratory infection and immunization strategies.

multidisciplinary sciences
Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015) – short version

R. Baron,A. Binder,R. Biniek,S. Braune,H. Buerkle,P. Dall,Sueha Demirakça,R. Eckardt,Verena Eggers,Ingolf Eichler,I. Fietze,S. Freys,A. Fründ,L. Garten,B. Gohrbandt

DOI: https://doi.org/10.3205/000223

2015-11-12

Abstract:In 2010, under the guidance of the DGAI (German Society of Anaesthesiology and Intensive Care Medicine) and DIVI (German Interdisciplinary Association for Intensive Care and Emergency Medicine), twelve German medical societies published the “Evidence- and Consensus-based Guidelines on the Management of Analgesia, Sedation and Delirium in Intensive Care”. Since then, several new studies and publications have considerably increased the body of evidence, including the new recommendations from the American College of Critical Care Medicine (ACCM) in conjunction with Society of Critical Care Medicine (SCCM) and American Society of Health-System Pharmacists (ASHP) from 2013. For this update, a major restructuring and extension of the guidelines were needed in order to cover new aspects of treatment, such as sleep and anxiety management. The literature was systematically searched and evaluated using the criteria of the Oxford Center of Evidence Based Medicine. The body of evidence used to formulate these recommendations was reviewed and approved by representatives of 17 national societies. Three grades of recommendation were used as follows: Grade “A” (strong recommendation), Grade “B” (recommendation) and Grade “0” (open recommendation). The result is a comprehensive, interdisciplinary, evidence and consensus-based set of level 3 guidelines. This publication was designed for all ICU professionals, and takes into account all critically ill patient populations. It represents a guide to symptom-oriented prevention, diagnosis, and treatment of delirium, anxiety, stress, and protocol-based analgesia, sedation, and sleep-management in intensive care medicine.
Assessment of antibodies in the upper and lower human respiratory tract at steady state and after respiratory viral infection

Marios Koutsakos,Jackson S Turner,M Cristina Vazquez Guillamet,Daniel Reynolds,Tingting Lei,Derek E Byers,Ali H Ellebedy,Philip A Mudd

DOI: https://doi.org/10.1002/cti2.1460

2023-08-08

Abstract:Objectives: There is an increasing appreciation for the need to study mucosal antibody responses in humans. Our aim was to determine the utility of different types of samples from the human respiratory tract, specifically nasopharyngeal (NP) swabs obtained for diagnostic purposes and bronchoalveolar lavage (BAL) obtained in outpatient and inpatient settings. Methods: We analysed antibody levels in plasma and NP swabs from 67 individuals with acute influenza as well as plasma and BAL from individuals undergoing bronchoscopy, including five control subjects as well as seven moderately and seven severely ill subjects with a respiratory viral infection. Levels of α2-macroglobulin were determined in BAL and plasma to assess plasma exudation. Results: IgG and IgA were readily detectable in BAL and NP swabs, albeit at different ratios, while IgM levels were low. The total amount of antibody recovered from NP swabs varied greatly between study participants. Accordingly, the levels of influenza HA-specific antibodies varied, and individuals with lower amounts of total Ig in NP swabs had undetectable levels of HA-specific Ig. Similarly, the total amount of antibody recovered from BAL varied between study participants. However, severely ill patients showed evidence of increased plasma exudation, which may confound analysis of their BAL samples for mucosal antibodies. Conclusion: Nasopharyngeal swabs collected for diagnostic purposes may have utility in assessing antibodies from the human nasal mucosa, but variability in sampling should be accounted for. BAL samples can be utilised to study antibodies from the lower respiratory tract, but the possibility of plasma exudation should be excluded.
Antiviral innate immune memory in alveolar macrophages following SARS-CoV-2 infection ameliorates secondary influenza A virus disease

Alexander Lercher,Jin-Gyu Cheong,Michael J Bale,Chenyang Jiang,Hans-Heinrich Hoffmann,Alison W Ashbrook,Tyler Lewy,Yue S Yin,Corrine Quirk,Emma J DeGrace,Luis Chiriboga,Brad R Rosenberg,Steven Z Josefowicz,Charles M Rice

DOI: https://doi.org/10.1016/j.immuni.2024.08.018

IF: 32.4

2024-09-27

Immunity

Abstract:Pathogen encounter can result in epigenetic remodeling that shapes disease caused by heterologous pathogens. Here, we examined innate immune memory in the context of commonly circulating respiratory viruses. Single-cell analyses of airway-resident immune cells in a disease-relevant murine model of SARS-CoV-2 recovery revealed epigenetic reprogramming in alveolar macrophages following infection. Post-COVID-19 human monocytes exhibited similar epigenetic signatures. In airway-resident macrophages, past SARS-CoV-2 infection increased activity of type I interferon (IFN-I)-related transcription factors and epigenetic poising of antiviral genes. Viral pattern recognition and canonical IFN-I signaling were required for the establishment of this innate immune memory and augmented secondary antiviral responses. Antiviral innate immune memory mounted by airway-resident macrophages post-SARS-CoV-2 was necessary and sufficient to ameliorate secondary disease caused by influenza A virus and curtailed hyperinflammatory dysregulation and mortality. Our findings provide insights into antiviral innate immune memory in the airway that may facilitate the development of broadly effective therapeutic strategies.
Impact of variants and vaccination on nasal immunity across three waves of SARS-CoV-2

Jaclyn M. Long,Vincent N. Miao,Anna H. Owings,Ying Tang,Joshua D. Bromley,Samuel W. Kazer,Kyle Kimler,Chelsea Asare,Carly G. K. Ziegler,Samira Ibrahim,Tasneem Jivanjee,Micayla George,Andrew W. Navia,Riley S. Drake,Adam Parker,Benjamin C. Billingsley,Paul Dotherow,Spurthi Tarugu,Sai K. Kota,Hannah Laird,T. Grant Wichman,Yesenia T. Davis,Neha S. Dhaliwal,Yilianys Pride,Yanglin Guo,Michal Senitko,Jessie Harvey,John T. Bates,Gill Diamond,Michael R. Garrett,D. Ashley Robinson,I. J. Frame,Jonathan J. Lyons,Tanya O. Robinson,Alex K. Shalek,Bruce H. Horwitz,Sarah C. Glover,Jose Ordovas-Montanes

DOI: https://doi.org/10.1101/2024.05.29.596308

2024-05-29

Abstract:SARS-CoV-2 infection and COVID-19 disease vary with respect to viral variant and host vaccination status. However, how vaccines, emergent variants, and their intersection shift host responses in the human nasal mucosa remains uncharacterized. We and others have shown during the first SARS-CoV-2 wave that a muted nasal epithelial interferon response at the site of infection underlies severe COVID-19. We sought to further understand how upper airway cell subsets and states associate with COVID-19 phenotypes across viral variants and vaccination. Here, we integrated new single-cell RNA-sequencing (scRNA-seq) data from nasopharyngeal swabs collected from 67 adult participants during the Delta and Omicron waves with data from 45 participants collected during the original (Ancestral) wave in our prior study. By characterizing detailed cellular states during infection, we identified changes in epithelial and immune cells that are both unique and shared across variants and vaccination status. By defining SARS-CoV-2 RNA+ cells for each variant, we found that Delta samples had a marked increase in the abundance of viral RNA+ cells. Despite this dramatic increase in viral RNA+ cells in Delta cases, the nasal cellular compositions of Delta and Omicron exhibit greater similarity, driven partly by myeloid subsets, than the Ancestral landscapes associated with specialized epithelial subsets. We found that vaccination prior to infection was surprisingly associated with nasal macrophage recruitment and activation rather than adaptive immune cell signatures. While patients with severe disease caused by Ancestral or Delta variants had muted interferon responses, Omicron-infected patients had equivalent interferon responses regardless of disease severity. Our study defines the evolution of cellular targets and signatures of disease severity in the upper respiratory tract across SARS-CoV-2 variants, and suggests that intramuscular vaccines shape myeloid responses in the nasal mucosa upon SARS-CoV-2 infection.

Immunology
Evolution of antibody immunity to SARS-CoV-2

Christian Gaebler,Zijun Wang,Julio C. C. Lorenzi,Frauke Muecksch,Shlomo Finkin,Minami Tokuyama,Alice Cho,Mila Jankovic,Dennis Schaefer-Babajew,Thiago Y. Oliveira,Melissa Cipolla,Charlotte Viant,Christopher O. Barnes,Yaron Bram,Gaëlle Breton,Thomas Hägglöf,Pilar Mendoza,Arlene Hurley,Martina Turroja,Kristie Gordon,Katrina G. Millard,Victor Ramos,Fabian Schmidt,Yiska Weisblum,Divya Jha,Michael Tankelevich,Gustavo Martinez-Delgado,Jim Yee,Roshni Patel,Juan Dizon,Cecille Unson-O’Brien,Irina Shimeliovich,Davide F. Robbiani,Zhen Zhao,Anna Gazumyan,Robert E. Schwartz,Theodora Hatziioannou,Pamela J. Bjorkman,Saurabh Mehandru,Paul D. Bieniasz,Marina Caskey,Michel C. Nussenzweig

DOI: https://doi.org/10.1038/s41586-021-03207-w

IF: 64.8

2021-01-18

Nature

Abstract:Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected 78 million individuals and is responsible for over 1.7 million deaths to date. Infection is associated with development of variable levels of antibodies with neutralizing activity that can protect against infection in animal models<sup>1,2</sup>. Antibody levels decrease with time, but the nature and quality of the memory B cells that would be called upon to produce antibodies upon re-infection has not been examined. Here we report on the humoral memory response in a cohort of 87 individuals assessed at 1.3 and 6.2 months after infection. We find that IgM, and IgG anti-SARS-CoV-2 spike protein receptor binding domain (RBD) antibody titres decrease significantly with IgA being less affected. Concurrently, neutralizing activity in plasma decreases by fivefold in pseudotype virus assays. In contrast, the number of RBD-specific memory B cells is unchanged. Memory B cells display clonal turnover after 6.2 months, and the antibodies they express have greater somatic hypermutation, increased potency and resistance to RBD mutations, indicative of continued evolution of the humoral response. Analysis of intestinal biopsies obtained from asymptomatic individuals 4 months after the onset of coronavirus disease-2019 (COVID-19), using immunofluorescence, or polymerase chain reaction, revealed persistence of SARS-CoV-2 nucleic acids and immunoreactivity in the small bowel of 7 out of 14 volunteers. We conclude that the memory B cell response to SARS-CoV-2 evolves between 1.3 and 6.2 months after infection in a manner that is consistent with antigen persistence.

multidisciplinary sciences
Nasal tissue-resident memory CD4+ T cells persist after influenza A virus infection and provide heterosubtypic protection

Nimitha R Mathew,Romain Gailleton,Lydia Scharf,Karin Schön,Anneli Strömberg,Nils Lycke,Mats Bemark,Ka-Wei Tang,Davide Angeletti

DOI: https://doi.org/10.1101/2024.07.06.602325

2024-07-10

Abstract:CD4 tissue-resident memory T (CD4 TRM) cells are crucial adaptive immune components involved in preventing influenza A virus (IAV) infection. Despite their importance, their physiological role in the upper respiratory tract, the first site of contact with IAV, remains unclear. Here, we find that, after IAV infection, antigen-specific CD4 TRM persist in the nasal tissue (NT) compartment and play a prime role in local viral clearance. Single cell RNA sequencing analysis reveals that NT CD4 TRM are heterogeneous and transcriptionally distinct as compared to their lung counterparts. Mechanistically, we demonstrate that the CXCR6-CXCL16 axis is involved in CD4 TRM residency in the NT. Furthermore, we show that the NT of mice and humans contains a high frequency of IL-17-producing CD4 TRM that aid in local viral clearance and in reducing tissue damage. Collectively, our results support a robust physiological role for nasal tissue CD4 TRM in preventing IAV infection.

Immunology
Immune memory in convalescent patients with asymptomatic or mild COVID-19

Quan-Xin Long,Yan-Jun Jia,Xin Wang,Hai-Jun Deng,Xiao-Xia Cao,Jun Yuan,Liang Fang,Xu-Rong Cheng,Chao Luo,An-Ran He,Xiao-Jun Tang,Jie-li Hu,Yuan Hu,Ni Tang,Xue-Fei Cai,De-Qiang Wang,Jie Hu,Jing-Fu Qiu,Bei-Zhong Liu,Juan Chen,Ai-long Huang

DOI: https://doi.org/10.1038/s41421-021-00250-9

IF: 38.079

2021-03-25

Cell Discovery

Abstract:Abstract It is important to evaluate the durability of the protective immune response elicited by primary infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we systematically evaluated the SARS-CoV-2-specific memory B cell and T cell responses in healthy controls and individuals recovered from asymptomatic or symptomatic infection approximately 6 months prior. Comparatively low frequencies of memory B cells specific for the receptor-binding domain (RBD) of spike glycoprotein (S) persisted in the peripheral blood of individuals who recovered from infection (median 0.62%, interquartile range 0.48-0.69). The SARS-CoV-2 RBD-specific memory B cell response was detected in 2 of 13 individuals who recovered from asymptomatic infection and 10 of 20 individuals who recovered from symptomatic infection. T cell responses induced by S, membrane (M), and nucleocapsid (N) peptide libraries from SARS-CoV-2 were observed in individuals recovered from coronavirus disease 2019 (COVID-19), and cross-reactive T cell responses to SARS-CoV-2 were also detected in healthy controls.

cell biology
The Immune Response to Respiratory Viruses: From Start to Memory

Tom D.Y. Reijnders,Alex R. Schuurman,Tom van der Poll

DOI: https://doi.org/10.1055/s-0041-1736459

2021-12-01

Seminars in Respiratory and Critical Care Medicine

Abstract:Abstract Biomedical research has long strived to improve our understanding of the immune response to respiratory viral infections, an effort that has become all the more important as we live through the consequences of a pandemic. The disease course of these infections is shaped in large part by the actions of various cells of the innate and adaptive immune systems. While these cells are crucial in clearing viral pathogens and establishing long-term immunity, their effector mechanisms may also escalate into excessive, tissue-destructive inflammation detrimental to the host. In this review, we describe the breadth of the immune response to infection with respiratory viruses such as influenza and respiratory syncytial virus. Throughout, we focus on the host rather than the pathogen and try to describe shared patterns in the host response to different viruses. We start with the local cells of the airways, onto the recruitment and activation of innate and adaptive immune cells, followed by the establishment of local and systemic memory cells key in protection against reinfection. We end by exploring how respiratory viral infections can predispose to bacterial superinfection.

respiratory system,critical care medicine

Covalent binding of ethidium azide analogs to Salmonella DNA in vivo: competition by ethidium bromide.

Induction of Autonomous Memory Alveolar Macrophages Requires T Cell Help and is Critical to Trained Immunity

Innate Immune Memory Of Tissue-Resident Macrophages And Trained Innate Immunity: Re-Vamping Vaccine Concept And Strategies

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

The effect of neurosphere culture conditions on the cellular metabolism of glioma cells.

Behavior-based involvement recognized in OSHA voluntary protection programs. Meaningful employee involvement satisfies OSHA and helps the corporate bottom line.

Tissue resident memory T cells in the respiratory tract

Human Nasal and Lung Tissues Infected Ex Vivo with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract

Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children

Innate memory against viruses

Temporal High-Resolution Atlas of Human Blood Leukocyte Composition in Response to Respiratory Virus Inoculation

Lung-resident memory B cells established after pulmonary influenza infection display distinct transcriptional and phenotypic profiles

Immune cell residency in the nasal mucosa may partially explain respiratory disease severity across the age range

Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015) – short version

Assessment of antibodies in the upper and lower human respiratory tract at steady state and after respiratory viral infection

Antiviral innate immune memory in alveolar macrophages following SARS-CoV-2 infection ameliorates secondary influenza A virus disease

Impact of variants and vaccination on nasal immunity across three waves of SARS-CoV-2

Evolution of antibody immunity to SARS-CoV-2

Nasal tissue-resident memory CD4+ T cells persist after influenza A virus infection and provide heterosubtypic protection

Immune memory in convalescent patients with asymptomatic or mild COVID-19

The Immune Response to Respiratory Viruses: From Start to Memory